Skip to main content
Scroll Top
Menu
WHO WE ARE
ABOUT US
TEAM
MANAGEMENT TEAM
INDUSTRIAL ADVISORS
SCIENTIFIC COUNCIL
PARTNERS
R&D
INTRODUCTION
TECH
NEUROSTIMULATION
PHOTOBIOMODULATION
ALZHEIMER
CLINICAL TRIAL
PATHOPHYSIOLOGY
TECHNOLOGY
CONCUSSION
CLINICAL TRIAL
PATHOPHYSIOLOGY
TECHNOLOGY
SOLUTIONS
CLINICAL RESEARCH
PRECLINICAL RESEARCH
CONCUSSION
NEWS
ALL
PRESS ARTICLES
VIDEOS
EVENTS
SCIENTIFIC PUBLICATIONS
ALL
SCIENTIFIC ARTICLES
ORAL COMMUNICATIONS
POSTED COMMUNICATIONS
CONTACT
FAQ
Executive summary
Français
Menu
WHO WE ARE
ABOUT US
TEAM
MANAGEMENT TEAM
INDUSTRIAL ADVISORS
SCIENTIFIC COUNCIL
PARTNERS
R&D
INTRODUCTION
TECH
NEUROSTIMULATION
PHOTOBIOMODULATION
ALZHEIMER
CLINICAL TRIAL
PATHOPHYSIOLOGY
TECHNOLOGY
CONCUSSION
CLINICAL TRIAL
PATHOPHYSIOLOGY
TECHNOLOGY
SOLUTIONS
CLINICAL RESEARCH
PRECLINICAL RESEARCH
CONCUSSION
NEWS
ALL
PRESS ARTICLES
VIDEOS
EVENTS
SCIENTIFIC PUBLICATIONS
ALL
SCIENTIFIC ARTICLES
ORAL COMMUNICATIONS
POSTED COMMUNICATIONS
CONTACT
FAQ
Executive summary
Français
Home
Alzheimer
Alzheimer’s disease: REGEnLIFE accelerates its Light4Life clinical trial with the opening of a new trial site at Lyon University Hospital, Hôpital des Charpennes
Alzheimer
1 April 2026
Alzheimer’s disease: REGEnLIFE accelerates its Light4Life clinical trial with the opening of a new trial site at Lyon University Hospital, Hôpital des Charpennes
MedInTechs 2026 – Parc Floral de Paris | 9 & 10 March
Alzheimer
Past Events
20 March 2026
MedInTechs 2026 – Parc Floral de Paris | 9 & 10 March
IN THE SPOTLIGHT – REGEnLIFE: At the crossroads of medicine and physics – Pharmaceutiques Magazine No. 335 / March 2026
Alzheimer
Concussions
16 March 2026
IN THE SPOTLIGHT – REGEnLIFE: At the crossroads of medicine and physics – Pharmaceutiques Magazine No. 335 / March 2026
Slowing down neurodegeneration with light
Alzheimer
16 March 2026
Slowing down neurodegeneration with light
REGEnLIFE, the French NeuroTech DeepTech company shortlisted for the 2025 Prix Galien USA
Alzheimer
16 March 2026
REGEnLIFE, the French NeuroTech DeepTech company shortlisted for the 2025 Prix Galien USA
“Conceiving an innovation is one thing; bringing it to fruition is quite another.” Guillaume Blivet wants to transform the lives of patients with neurological disorders
Alzheimer
Depression
Multiple sclerosis
16 March 2026
“Conceiving an innovation is one thing; bringing it to fruition is quite another.” Guillaume Blivet wants to transform the lives of patients with neurological disorders
Can Light Heal the Brain? REGEnLIFE Explores Photobiomodulation for Alzheimer’s
Alzheimer
Depression
Multiple sclerosis
15 March 2026
Can Light Heal the Brain? REGEnLIFE Explores Photobiomodulation for Alzheimer’s
[Initiatives] Two new centers open in Paris for a clinical trial on Alzheimer’s disease
Alzheimer
15 March 2026
[Initiatives] Two new centers open in Paris for a clinical trial on Alzheimer’s disease
Alzheimer’s: REGEnLIFE opens two new centres in Paris for its clinical trial
Alzheimer
15 March 2026
Alzheimer’s: REGEnLIFE opens two new centres in Paris for its clinical trial
Alzheimer’s disease: the promise of new Non-Invasive Brain Stimulation methods
Alzheimer
Posted Communications
5 March 2026
Alzheimer’s disease: the promise of new Non-Invasive Brain Stimulation methods
Neurointestinal stimulation: a new therapeutic approach for Alzheimer’s disease? News from the pivotal clinical trial LIGHT4LIFE
Alzheimer
Oral Communications
5 March 2026
Neurointestinal stimulation: a new therapeutic approach for Alzheimer’s disease? News from the pivotal clinical trial LIGHT4LIFE
Brain photobiomodulation: a potential treatment in Alzheimer’s and Parkinson’s diseases
Alzheimer
Scientific Articles
25 April 2025
Brain photobiomodulation: a potential treatment in Alzheimer’s and Parkinson’s diseases
1
2
…
4
Next
Get a Quote
